Pacific Edge Ltd(PFGTF)

Description: Pacific Edge Limited, a cancer diagnostic company, researches, develops, and commercializes diagnostic and prognostic tools for the early detection and management of cancers in New Zealand, the United States, Australia, and Singapore. It operates in two segments, Commercial and Research. The company offers Cxbladder, a genomic urine tests for the detection and management of bladder cancer. It is also developing Cxbladder Resolve, a product that identifies those patients who are likely to have aggressive or more advanced bladder cancer; Cxbladder Triage, a product that identifies patients with haematuria who have a low probability of bladder cancer; Cxbladder Detect that enables the non-invasive detection of bladder and other urinary tract cancers; and Cxbladder Monitor, which allows urologists to monitor bladder cancer patients for recurrence of the disease. In addition, the company is developing Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancers; and products for bladder, gastric, colorectal, endometrial cancers, and melanoma. Pacific Edge Limited was incorporated in 2001 and is headquartered in Dunedin, New Zealand.

---

Keywords: Medicine Cancer Disease Colorectal Cancer Melanoma Urology Bladder Cancer Cancer Syndrome Diagnostic And Prognostic Tools P16 Pacific Edge Limited

---

Home Page: www.pacificedgedx.com

Centre for Innovation
Dunedin, 9016
New Zealand
Phone: 64 3 577 6733

---

Officers

Exchange: PINK

Country: US : United States of America

Currency: US Dollar ($)